-
2006-07-18
10/466,460
2002-01-10
US 7,078,550 B2
2006-07-18
WO; PCT/EP02/00192; 20020110
WO; WO02/058016; 20020725
Johann Richter | Chukwuma Nwaonicha
2022-03-26
There are described silanyl phenols and naphthols of formula (1a) or (1b), wherein R1 is hydrogen; halogen; hydroxy; C1–C20alkyl; C3–C12cycloalkyl; C1–C20alkoxy; trifluoromethyl; pentafluoroethyl; mono- or di-C1–C5alkylamino; hydroxy-C1–C5alkyl; or phenyl, phenyl-C1–C20alkyl, phenoxy, phenyl-C1–C20alkoxy, naphthyl or naphthyl-C1–C20alkyl each unsubstituted or substituted by C1–C5alkyl, C3–C12cycloalkyl, C1–C5alkoxy, C3–C12cycloalkoxy, halogen, oxo, carboxy, carboxy-C1–C7alkyl ester, carboxy-C3–C12cycloalkyl ester, cyano, trifluoromethyl, pentafluoroethyl, amino, N,N-mono- or di-C1–C20alkylamino or by nitro; R2, R3 and R4 are each independently of the others hydrogen; C1–C20alkyl; or C3–C12-cycloalkyl; R5, R6 and R7 are each independently of the others C1–C20alkyl, C5–C10aryl, C1–C20alkoxy, phenyl-C1–C20alkyl, phenyl-C1–C20alkoxy, C2–C5alkenyl, —O—Si—(C1–C5alkyl)3; or O—Si—(C1–C5alkyl)2-O—Si(C1–C5alkyl)3 and n is 0 or 1. The compounds exhibit a pronounced activity against Gram positive and Gram negative bacteria, and also against yeasts and moulds
Get notified when new applications in this technology area are published.
C07F7/04 IPC
Compounds containing elements of Groups 4 or 14 of the Periodic System; Silicon compounds Esters of silicic acids
The present invention relates to selected silanyl phenols and naphthols, to the preparation of such compounds, to the use of such compounds for the antimicrobial treatment of surfaces, as antimicrobial active ingredients against Gram-positive and Gram-negative bacteria, yeasts and fungi and in the preservation of cosmetics, household products, textiles, plastics, and for use in disinfectants.
The compounds according to the invention correspond to the formula
wherein
C1–C20Alkyl denotes straight-chain or branched alkyl radicals, e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, amyl, isoamyl or tert-amyl, heptyl, octyl, isooctyl, nonyl, decyl, undecyl, dodecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl or eicosyl.
C1–C20Alkoxy denotes straight-chain or branched radicals, e.g. methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, isooctyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, tetradecyloxy, pentadecyloxy, hexadecyloxy, heptadecyloxy, octadecyloxy or eicosyloxy.
C3–C12Cycloalkyl denotes e.g. cyclopropyl, cyclobutyl, cyclopentyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cycloundecyl, cyclodocecyl and especially cyclohexyl.
In the context of the definitions given, alkenyl includes inter alia vinyl, allyl, isopropenyl, 2-butenyl, 3-butenyl, isobutenyl, n-penta-2,4-dienyl, 3-methyl-but-2-enyl, n-oct-2-enyl, n-dodec-2-enyl, isododecenyl, n-dodec-2-enyl or n-octadec-4-enyl.
C5-C10Aryl denotes phenyl or naphthyl.
Preference is given to compounds of formula (1a) or (1b), wherein
Especially preferred compounds of formula (1a) or (1b) are those wherein
Very special preference is given to compounds of formulae
wherin
Examples of very especially preferred compounds of the invention correspond to the formulae
The compounds according to the invention are prepared in very general terms by the addition of silanes that contain at least one Si—H bond to phenols or naphthols substituted as desired that have unsaturated side chains (hydrosilylation).
The invention relates also to the process for the preparation of silanyl phenols and naphthols of formulae (1a) and (1b). In the process a phenol or naphthol compound is etherified with an allyl halide (1st step), the resulting alkenyl phenyl ether compound is rearranged to form an alkenylphenyl compound (2nd step), and a silane compound that contains at least one Si—H bond is added to that compound (3rd step) according to the following Scheme:
In that reaction scheme
The hydrosilylation is carried out according to processes known per se in an inert organic solvent, preferably at elevated temperature, in the presence of catalytic amounts of a transition metal complex. Suitable complexes are, for example, generally complexes of the metals rhodium, iridium or cobalt, or especially carbonyls of the metals iron, cobalt, nickel, rhodium, ruthenium, manganese or chromium. Special preference is given to complexes of platinum or hexachloroplafinic acid H2PtCl6.
As starting compounds for the hydrosilylaton there are used alkenyl-phenols or -naphthols, which are prepared according to processes known per se, as described, for example, in Synthesis 1981, 310 for Friedel-Crafts allylation of phenols. The alkenyl-phenols or -naphthols are preferably prepared from readily obtainable alkenyl phenyl ethers by a Claisen rearrangement. The rearrangement reaction can be carried out with or without high-boiling solvents at temperatures of 200–250° C. The rearrangement is preferably carried out in ethylene glycol or its oligomers, or ethers thereof, especially in diethylene glycol dimethyl ether at 220° C. in a pressurised vessel. That procedure results in an especially pure reaction product.
The Invention relates also to compounds of formula
wherein
Silanyl phenols and naphthols of formula
wherein
They are therefore suitable as antimicrobial active ingredients and as preservatives in personal care preparations, for example shampoos, bath additives, hair-care products, liquid and solid soaps (based on synthetic surfactants and salts of saturated and/or unsaturated fatty acids), lotions and creams, deodorants, other aqueous or alcoholic solutions, e.g. cleansing solutions for the skin, moist cleansing cloths, oils or powders.
The invention accordingly relates also to a personal care preparation comprising at least one compound of formula (1c) and cosmetically tolerable carriers or adjuvants.
The personal care preparation according to the invention comprises from 0.01 to 15% by weight, preferably from 0.1 to 10% by weight, based on the total weight of the composition, of the compound of formula (1c), and cosmetically tolerable adjuvants.
Depending on the form of the personal care preparation, it will comprise, in addition to the silanyl phenol or naphthol of formula (1c), further constituents, for example sequestering agents, colourings, perfume oils, thickening or solidifying agents (consistency regulators), emollients, UV absorbers, skin-protective agents, antioxidants, additives that improve mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca and Mg salts of C14–C22-fatty acids, and optionally preservatives.
The personal care preparation according to the invention may be formulated as a water-in-oil or oil-in-water emulsion, as an alcoholic or alcohol-containing formulation, as a vesicular dispersion of an ionic or non-ionic amphiphilic lipid, as a gel, a solid stick or as an aerosol formulation.
As a water-in-oil or oil-in-water emulsion the cosmetically tolerable adjuvant preferably comprises from 5 to 50% of an oily phase, from 5 to 20% of an emulsifier and from 30 to 90% water. The oily phase may contain any oil suitable for cosmetic formulations, e.g. one or more hydrocarbon oils, a wax, a natural oil, a silicone oil, a fatty acid ester or a fatty alcohol. Preferred mono- or poly-ols are ethanol, isopropanol, propylene glycol, hexylene glycol, glycerol and sorbitol.
Cosmetic formulations according to the invention are used in various fields. For example, the following preparations especially come into consideration:
An antimicrobial soap has, for example, the following composition:
A shampoo has, for example, the following composition:
A deodorant has, for example, the following composition:
The invention relates also to an oral composition, comprising
Example of an oral composition:
The oral composition according to the invention may be, for example, in the form of a gel, a paste, a cream or an aqueous preparation (mouthwash).
The oral composition according to the invention may also comprise compounds that release fluoride ions which are effective against the formation of caries, for example inorganic fluoride salts, e.g. sodium, potassium, ammonium or calcium fluoride, or organic fluoride salts, e.g. amine fluorides, which are known under the trade name Olafluor.
The silanyl phenols and naphthols of formula (1c) according to the invention are also suitable for the treatment, especially preservation, of textile fibre materials. Such materials are undyed and dyed or printed fibre materials, e.g. of silk, wool, polyamide or polyurethanes, and especially cellulosic fibre materials of all kinds. Such fibre materials are, for example, natural cellulosic fibres, such as cotton, linen, jute and hemp, as well as cellulose and regenerated cellulose. Preferred suitable textile fibre materials are made of cotton.
The silanyl phenols and naphthols according to the invention are also suitable for the treatment of plastics, especially for imparting antimicrobial properties to or preserving plastics, e.g. polyethylene, polypropylene, polyurethane, polyester, polyamide, polycarbonate, latex etc. Fields of use therefore are, for example, floor coverings, plastics coatings, plastics container and packaging materials; kitchen and bathroom utensils (e.g. brushes, shower curtains; sponges, bathmats), latex, filter materials (air and water filters), plastics articles used in the field of medicine, e.g. dressing materials, syringes, catheters etc., so-called “medical devices”, gloves and mattresses.
Paper, for example papers used for hygiene purposes, may also be provided with antimicrobial properties using the silanyl phenols and naphthols according to the invention.
It is also possible for nonwovens, e.g. nappies/diapers, sanitary towels, panty liners, and cloths for hygiene and household uses, to be provided with antimicrobial properties in accordance with the invention.
The silanyl phenols and naphthols of formula (1c) are also used in washing and cleaning formulations, e.g. in liquid and powder detergents or fabric conditioners.
The silanyl phenols and naphthols of formula (1c) can be used especially also in household and all-purpose cleaners for cleaning and disinfecting hard surfaces.
A cleaning preparation has, for example, the following composition:
| 3.0% | octyl alcohol 4E0 |
| 1.3% | fatty alcohol C8–C10polyglucoside |
| 3.0% | isopropanol |
| ad 100% | water. |
In addition to preserving cosmetics and household products, it is also possible for technical products to be preserved and provided with antimicrobial properties; use as a biocide in technical processes is also possible, for example in paper treatment, especially in paper treatment liquors, printing thickeners of starch or cellulose derivatives, varnishes and paints.
The silanyl phenols and naphthols of formula (1c) are also suitable for the antimicrobial treatment of wood and for the antimicrobial treatment of leather, the preservation of leather and the provision of leather with antimicrobial properties.
The compounds according to the invention are also suitable for the protection of cosmetic products and household products from microbial damage.
The following Examples illustrate, but do not limit, the present invention.
The preparation of allylphenols in diethylene glycol dimethyl ether is described in general and the preparation of 2-methallyl-4-phenyl-phenol (101d), which is novel, is described in particular:
A mixture of 4.9 g (29 mmol) of 4-hydroxybiphenyl, 3.2 g (35 mmol) of methallyl chloride and 4.8 g (35 mmol) of anhydrous potassium carbonate in 100 ml of absolute DMF is stirred under nitrogen for 12 hours at 85° C. After filtration and removal of the solvent, the ether can be used without further purification for the subsequent rearrangement; yield 6.0 g (92% of theory).
2.2 g (10 mmol) of the previously prepared ether are heated at reflux under nitrogen for 48 hours in 20 ml of o-dichlorobenzene at 180° C. The phenol is then separated from the unreacted ether by extracting the reaction mass, which has been diluted with 50 ml of methylene chloride, several times with sodium hydroxide solution at pH 11. After customary aqueous working-up, the product is obtained in sufficient purity for the subsequent hydrosilylation
General Preparation of o-allylphenols in Diethylene Glycol Dimethyl Ether:
Approximately 25 mmol of the appropriate allyl phenyl ether are stirred in 10 ml of dry diethylene glycol dimethyl ether in a pressurised vessel for 12 hours at 220° C. The mixture is then diluted with approximately 40 ml of petroleum ether and washed twice with water. The isolated crude product is purified by distillation at 10−2 mbar. The expected structures are confirmed by GC/MS and 1H-NMR.
| Yield | |||
| Compound of | (% of | ||
| formula | Structure | theory) | 1H-NMR |
| (II) | 50 | (CDCl3): 6.8–7.45 (m, 8H, arom.-H), 5.1(s, 1H, OH), 4.8/4.85 (s, 1H, ═CH), 3.35(s, 2H, CH2), 1.7 (s, 3H, CH3) | |
| (III) | 86 | (DMSO-d6): 9.06(s, 1H, OH), 6.76–7.24(m, 3H, arom.-H), 4.72/4.82(s, 1H, ═CH), 3.32(s,2H, PhCH2), 1.77(s, 3H, CH3), 1.32(s, 9H, CCH3) | |
| (IV) | 78 | (DMSO-d6): 9.02(s, 1H, OH), 6.66–6.82(m, 3H, arom.-H), 5.88–5.99(m, 1H, ═CH),4.98/5.02(dd, 2H, ═CH2), 3.24(d, 2H, PhCH2),2.16(s, 3H, CH3) | |
| (V) | 75 | (DMSO-d6): 8.76(s, 1H, OH), 6.52–6.66(m, 3H, arom.-H), 5.82–5.95(m, 1H, ═CH),4.93/4.97(dd, 2H, ═CH2), 3.58(s, 3H, CH3),3.19(d, 2H, PhCH2) | |
According to the varying r activity of the types of silanes used, the hydrosilylations are carried out according to two similar procedures, which will be described hereinbelow by way of example. Yield and 1H-NMR data are then given in Table form. With the exception of the compound of formula (106), all the compounds are novel.
2.9 mmol of the appropriate allylphenol are dissolved under nitrogen in 10 ml of absolute toluene together with a drop of Karstedt catalyst (platinum complex in divinyl-tetramethyl-disiloxane) and heated to 80° C. At that temperature, 3.5 mmol of the appropriate silane are added dropwise and then the mixture is stirred for a further 5 hours at that temperature. After cooling and removal of the solvent, finally under a high vacuum, the residue is purified by flash chromatography over silica gel (eluant: toluene). The products are obtained in the form of pale, viscous oils, and GC/MS and 1H-NMR agree with the expected structures (Table 2):
| TABLE 2 | |||
| Yield (% of | |||
| Compound of | theory, based | 1H-NMR (CDCl3) | |
| formula | Structure | on phenol) | [ppm] |
| (101) | 45% | 6.7–7.25(m, 8H, arom.-H), 4.9(s, 1H, OH),2.55/2.25(dd, 1H, PhCH), 1.85(m, 1H, CH),0.85(d, 3H, CH3), 0.55/0.35(dd, 1H, SiCH),0(s, 18H, SiCH3), −0.1(s, 3H, SiCH3) | |
| (102) | 72% | 6.55–6.8(m, 3H, arom.-H), 5.35(s, 1H, OH),3.8(s, 3H, OCH3), 2.45(t, 2H, PhCH2),1.55(m, 2H, PhCH2CH2), 0.4(t, 2H, SiCH2),0.05(s, 18H, SiCH3), −0.05(s, 3H, SiCH3) | |
| (103) | 54% | 6.85–7.45(m, 8H, arom.-H), 5.0(s, 1H, OH),2.65/2.35(dd, 1H, PhCH), 1.95(m, 1H, CH),0.9(d, 3H, CH3), 0.55/0.4(dd, 1H, SiCH),0.05(s, 18H, SiCH3), 0(s, 3H, SiCH3) | |
| (104) | 62% | 6.65–4.05(m, 4H, arom.-H), 4.15(s, 1H, OH),2.5(t, 2H, PhCH2), 1.55(m, 2H, CH2CH2CH2),0.45(t, 2H, SiCH2), 0(s, 18H, SiCH3),−0.1(s, 3H, SiCH3) | |
| (105) | 33% | 6.65–7.05(m, 4H, arom.-H), 4.65(s, 1H, OH),2.5(t, 2H, PhCH2), 1.6(m, 2H, CH2CH2CH2),0.55(t, 2H, CH2Si), .05(s, 15H, SiCH3),−0.05(s, 6H, SiCH3) | |
| (106) | 34% | 6.7–7.25(m, 4H, arom.-H), .65(s, 1H, OH),2.55(t, 2H, PhCH2), 1.6(m, 2H, CH2CH2CH2),0.55(t, 2H, CH2Si), 0(s, 15H, SiCH3) | |
| (107) | 52% | 6.65–7.5(m, 9H, arom.-H), 4.5(s, 1H, OH),2.5(t, 2H, PhCH2), 1.55(m, 2H, CH2CH2CH2),0.85(t, 2H, CH2Si), 0.2(s, 6H, SiCH3) | |
| (108) | 61% | 1H-NMR(DMSO-d6): 8.81(s, 1H, OH), 6.61–6.93(m, 3H, arom. H), 2.37(d, 2H, PhCH2),1.87(m, 1H, CH), 1.18(s, 9H, C(CH3)3), 0.82(d,3H,CH3), 0.57/0.27(dd, 1H, SiCH),0(s, 18H, SiCH3), −0.07(s, 3H, SiCH3)13C ok | |
| (109) | 88% | 1H-NMR(DMSO-d6): 8.81(s, 1H, OH), 6.56–6.72(m, 3H, arom.-H), 2.4(t, 2H, PhCH2),2.08(s, 3H, CH3), 1.46(m, 2H, CH2CH2),0.40(t, 2H, CH2Si), 0(s, 18H, Si(CH3)3),−0.08(s, 3H, SiCH3)13C ok | |
| (110) | 51% | 1H-NMR(DMSO-d6): 8.62(s, 1H, OH), 6.45–6.65(m, 3H, arom.-H), 3.57(s, 3H, OCH3),2.42(t, 2H, PhCH2), 1.47(m, 2H, CH2CH2),0.40(t, 2H, CH2Si), 0(s, 18h, Si(CH3)3),−0.08(s, 3H, SiCH3)13C ok | |
| (111) | 42% | 1H-NMR(DMSO-d6): 8.44(s, 1H, OH), 6.30–7.30(m, 8H, arom.-H), 3.40(s, 3H, OCH3),2.26(t, 2H, PhCH2), 1.30(m, 2H, CH2CH2),0.53(t, 2H, CH2Si), 0(s, 6H, SiCH3)13C ok | |
| (112) | 30% | 1H-NMR(DMSO-d6): 9.43(s, 1H, OH), 6.68–6.98(m, 3H, arom.-H), 2.46(t, 2H, PhCH2),1.50(m, 2H, CH2CH2), 0.49(t, 2H, CH2Si),0(s, 15H, SiCH3, −0.06(s, 6H, SiCH3)13C ok | |
| (113) | 42% | 1H-NMR(DMSO-d6): 8.81(s, 1H, OH), 6.59–6.92(m, 3H, arom.-H), 2.29/2.44(dd, 1H, PhCH), 1.89(m, 1H, CH3CH),1.16(s, 9H, C(CH3)3), 0.81(d, 3H, CHCH3),0.39/0.62(dd, 1H, CHSi), 0(s, 15H, SiCH3),−0.08(s, 6H, SiCH3)13C ok | |
| (114) | 53% | 1H-NMR(DMSO-d6): 8.83(s, 1H, OH), 6.58–6.76(m, 3H, arom.-H), 2.43(t, 2H, PhCH2),2.10(s, 3H, CH3), 1.48(m, 2H, CH2CH2),0.49(t, 2H, CH2Si), 0(s, 9H, SiCH3), −0.01(s, 6H, SiCH3)13C ok | |
| (115) | 70% | 1H-NMR(DMSO-d6): 9.46(s, 1H, OH), 6.67–7.04(m, 3H, arom.-H), 2.47(t, 2H, PhCH2),1.50(m, 2H, CH2CH2), 0.48(t, 2H, CH2Si),0(s, 9H, SiCH3), −0.01(s, 6H, SiCH3)13C ok | |
| (116) | 65% | 1H-NMR/DMSO-d6): 8.85(s, 1H, OH), 7.1–8.15(m, 6H, arom.-H), 2.75(t, 2H, PhCH2),1.55(m, 2H, CH2CH2), 0.45(t, 2H, CH2Si), 0(s,18H, SiCH3), −0.1(s, 3H, SiCH3) | |
| (117) | 75% | 1H-NMR(DMSO-d6): 8.85(s, 1H, OH), 7.1–8.15(m, 6H, arom.-H), 2.6(d, 2H, PhCH2),1.95(m, 1H, CH), 0.85(d, 3H, CH3), 0.6/0.35(dd, 1H, SiCH), 0(s, 18H, SiCH3), −0.1(s, 3H, SiCH3) | |
2.9 mmol of the appropriate allylphenol are dissolved under nitrogen in 10 ml of absolute xylene together with a drop of Karstedt catalyst (platinum complex in divinyl-tetramethyl-disiloxane) and 3.5 mmol of the appropriate silane. The reaction mixture is maintained at reflux for 48 hours. After cooling and removal of the solvent, finally under a high vacuum, the residue is purified by flash chromatography over silica gel (eluant: xylene). The products are obtained in the form of pale, viscous oils, and GC/MS and 1H-NMR agree with the expected structures (Table 3):
| TABLE 3 | |||
| Yield (% of | |||
| Compound of | theory, based | 1H-NMR (CDCl3) | |
| formula | Structure | on phenol) | [ppm] |
| (118) | 41% | — | |
| (119) | 29% | 1H-NMR(CDCl3): 6.48–7.34(m, 8H, arom.-H),4.42(s, 1H, OH), 2.39(t, 2H, PhCH2), 1.45(m, 2H, CH2CH2CH2), 0.65(t, 2H, CH2Si), 0.1(s, 6H, SiCH3)13C ok | |
| (120) | 25% | 1H-NMR(DMSO-d6): 8.94(s, 1H, OH), 6.41–7.22(m, 13H, arom.-H). 2.09/2.24(dd, 1H, PhCH), 1.69(m, 1H, CH3CH), 0.56(d, 3H, CH3), 0.40/0.65(dd, 1H, CHSi), 0(s, 6H,SiCH3)13C ok | |
| (121) | 37% | 1H-NMR(DMSO-d6): 8.65(s, 1H, OH), 6.8–7.95(m, 11H, arom.-H), 2.45/2.35(dd, 1H, PhCH), 1.75(m, 1H, CH),0.75/0.45(dd, 1H, CHSi), 0.6(d, 3H, CH3),0(s, 6H, SiCH3) | |
| Medium: | casein/soybean flour peptone agar (Merck) |
| *Sabouraud 4% glucose agar (Merck) | |
| Dilution medium: | sterile 0.85% NaCl solution |
| Test organisms: | Staphylococcus aureus ATCC 9144 |
| Escherichia coli NCTC 8196 | |
| Pseudomonas aeruginosa CIP A-22 | |
| Candida albicans ATCC 10231 | |
| *Aspergillus niger ATCC 6275 | |
| Incubation: | 24 hours at 37° C. |
| *3 days at 28° C. | |
| Test solution: | 1% stock solutions of all the test substances in a suit- |
| able solvent are prepared and diluted in serial dilutions | |
| to final concentrations of from 1000 ppm to 10 ppm. | |
0.3 ml of each dilution stage is mixed with 15 ml of still-liquid nutrient medium. After the nutrient medium has solidified, 10 μl of each of the following organism dilutions of the test strains in 0.85% NaCl solution are spotted onto the agar medium:
| Staphylococcus aureus ATCC 9144 | 1:100 | dilution | |
| Escherichia coli NCTC 8196 | 1:1000 | dilution | |
| Pseudomonas aeruginosa CIP A-22 | 1:1000 | dilution | |
| Candida albicans ATCC 10231 | 1:10 | dilution | |
| Aspergillus niger ATCC 6275 | 1:10 | dilution | |
The plates are incubated for 24 hours at 37° C. (A. niger 3 days at 28° C.) and then the highest dilution (lowest concentration) of the test substance at which growth is just no longer discernible (corresponds to the MIC) is determined.
The results are shown in Tables 3a and 3b.
| TABLE 3a |
| MIC values in ppm |
| Compound of formula |
| Microorganisms | (101) | (102) | (118) | (104) |
| Staphylococcus aureus | 1000 | >1000 | 4 | 8 |
| ATCC 9144 | ||||
| Escherichia coli NCTC 8196 | >1000 | >1000 | >1000 | >1000 |
| Pseudomonas aeruginosa | >1000 | >1000 | >1000 | >1000 |
| CIP A-22 | ||||
| Candida albicans ATCC 10231 | >1000 | >1000 | >1000 | >1000 |
| Aspergillus niger ATCC 6275 | >1000 | >1000 | >1000 | >1000 |
| TABLE 3b |
| MIC values in ppm |
| Compound of formula |
| Microorganisms | (103) | (105) | (107) | (106) |
| Staphylococcus aureus | >560 | 15.6 | 1.9 | 7.8 |
| ATCC 9144 | ||||
| Staphylococcus hominis | >560 | >1000 | 7.8 | 31.2 |
| DSM 20328 | ||||
| Corynebacterium xerosis | 17.5 | 3.9 | 1.9 | 7.8 |
| ATCC 373 | ||||
| Enterococcus hirae ATCC 10541 | >560 | 15.6 | 3.9 | 15.6 |
| Escherichia coli NCTC 8196 | >560 | >1000 | >1000 | >1000 |
| Pseudomonas aeruginosa | >560 | >1000 | >1000 | >1000 |
| CIP A-22 | ||||
| Candida albicans ATCC 10231 | >560 | >1000 | 125 | >1000 |
| Aspergillus niger ATCC 6275 | >560 | >1000 | 15.6 | 31.2 |
| TABLE 3c |
| MIC values in ppm |
| Compound of formula |
| Microorganisms | (108) | (109) | (110) | (119) | (111) |
| Staphylococcus aureus | 0 | 15 | 250 | 4 | 125 |
| ATCC 9144 | |||||
| Corynebacterium xerosis | 8 | 4 | 4 | 2 | 8 |
| ATCC 373 | |||||
| Escherichia coli NCTC | >1000 | >1000 | >1000 | >1000 | >1000 |
| 8196 | |||||
| Pseudomonas aeruginosa | >1000 | >1000 | >1000 | >1000 | >1000 |
| CIP A-22 | |||||
| Candida albicans ATCC | >1000 | >1000 | >1000 | 62 | >1000 |
| 10231 | |||||
| Aspergillus niger ATCC | >1000 | >1000 | >1000 | 62 | >1000 |
| 6275 | |||||
| TABLE 3d |
| MIC values in ppm |
| Compound of formula |
| Microorganisms | (112) | (120) | (113) | (114) | (115) |
| Staphylococcus aureus | 7 | 8 | >1000 | 8 | 15 |
| ATCC 9144 | |||||
| Corynebacterium xerosis | 2 | 4 | 62 | 8 | 8 |
| ATCC 373 | |||||
| Escherichia coli NCTC | >1000 | >1000 | >1000 | >1000 | 250 |
| 8196 | |||||
| Pseudomonas aeruginosa | >1000 | >1000 | >1000 | >1000 | >1000 |
| CIP A-22 | |||||
| Candida albicans ATCC | >1000 | >1000 | >1000 | >1000 | 500 |
| 10231 | |||||
| Aspergillus niger ATCC | >1000 | >1000 | >1000 | >1000 | 500 |
| 6275 | |||||
| TABLE 3e |
| MIC values in ppm |
| Compound of formula |
| Microorganisms | (121) | (116) | (117) |
| Staphylococcus aureus ATCC 9144 | >1000 | >1000 | >1000 |
| Staphylococcus hominis DSM 20328 | >1000 | >1000 | >1000 |
| Corynebacterium xerosis ATCC 373 | 250 | 500 | 1000 |
| Escherichia coli ATCC 10536 | >1000 | >1000 | >1000 |
| Candida albicans ATCC 1023 | >1000 | >1000 | >1000 |
| Aspergillus niger ATCC 6275 | >1000 | >1000 | >1000 |
The results show a strong antimicrobial activity of the test substances against Gram-positive and Gram-negative bacteria and against fungi and yeasts.
1. A process for the preparation of a compound of formula
wherein a phenol or naphthol compound is etherified with an allyl halide (1st step), the resulting alkenyl phenyl ether compound is rearranged to form an alkenylphenyl compound (2nd step), and a silane compound that contains at least one Si—H bond is added to that compound according to the following Scheme:
wherein
R1 is hydrogen; halogen; hydroxy; C1–C20alkyl; C3–C12cycloalkyl; C1–C20alkoxy; trifluoromethyl; pentafluoroethyl; mono- or di-C1–C5alkylamino; hydroxy-C1–C5alkyl; or phenyl, phenyl-C1–C20alkyl, phenoxy, phenyl-C1–C20alkoxy, naphthyl or naphthyl-C1–C20alkyl each unsubstituted or substituted by C1–C5alkyl, C3–C12cycloalkyl, C1–C5alkoxy, C3–C12cycloalkoxy, halogen, oxo, carboxy, carboxy-C1–C7alkyl ester, carboxy-C3–C12cycloalkyl ester, cyano, trifluoromethyl, pentafluoroethyl, amino N,N-mono- or di-C1–C20alkylamino or by nitro;
R2, R3 and R4 are each independently of the others hydrogen; C1–C20alkyl; or C3–C12-cycloalkyl;
R5, R6 and R7 are each independently of the others C1–C20alkyl; C5–C10aryl; C1–C20alkoxy; phenyl-C1–C20alkyl; phenyl-C1–C20alkoxy, C2–C5alkenyl; —O—Si—(C1–C5alkyl)3; or —O—Si—(C1–C5alkyl)2-O—Si(C1–C5alkyl)3 and
n is 0 or 1,
there not being included compounds of formula (1a) wherein
R1, R2, R3 and R4 are hydrogen and R5, R6 and R7 are simultaneously methyl or ethyl.
2. A method for the antimicrobial treatment of a surface, which comprises contacting said surface with an antimicrobially effective amount of a silanyl phenol or naphthol compound of formula
wherein
R1 is hydrogen; halogen; hydroxy; C1–C20alkyl; C3–C12cycloalkyl; C1–C20alkoxy; trifluoromethyl; pentafluoroethyl; mono- or di-C1–C5alkylamino; hydroxy-C1–C5alkyl; or phenyl, phenyl-C1–C20alkyl, phenoxy, phenyl-C1–C20alkoxy, naphthyl or naphthyl-C1–C20alkyl each unsubstituted or substituted by C1–C5alkyl, C3–C12cycloalkyl, C1–C5alkoxy, C3–C12cycloalkoxy, halogen, oxo, carboxy, carboxy-C1–C7alkyl ester, carboxy-C3–C12cycloalkyl ester, cyano, trifluoromethyl, pentafluoroethyl, amino, N,N-mono- or di-C1–C20alkylamino or by nitro;
R2, R3 and R4 are each independently of the others hydrogen; C1–C20alkyl; or C3–C12-cycloalkyl;
R5, R6 and R7 are each independently of the others C1–C20alkyl; C5–C10aryl; C1–C20alkoxy; phenyl-C1–C20alkyl; phenyl-C1–C20alkoxy; C2–C5alkenyl; —O—Si—(C1–C5alkyl)3; or —O—Si—(C1–C5alkyl)2-O—Si(C1–C5alkyl)3; and
n is 0 or 1.
3. A method according to claim 2, wherein the compound of formula (1c) is used in the antimicrobial treatment, deodorisation and disinfection of the skin, mucosa and hair.
4. A method according to claim 2, wherein the compound of formula (1c) is used in the treatment of textile fibre materials.
5. A method according to claim 2, wherein the compound of formula (1c) is used in preservation.
6. A method according to claim 2, wherein the compound of formula (1c) is used in washing and cleaning formulations.
7. A method according to claim 2, wherein the compound of formula (1c) is used in imparting antimicrobial properties to and preserving plastics, paper, nonwoyens, wood or leather.
8. A method according to claim 2, wherein the compound of formula (1c) is used in imparting antimicrobial properties to and preserving technical products.
9. A method according to claim 2, wherein the compound of formula (1c) is used as a biocide in technical processes.
10. A personal care preparation, comprising from 0.01 to 15% by weight, based on the total weight of the composition, of the compound of formula (1c) defined according to claim 2, and cosmetically tolerable adjuvants.
11. An oral composition, comprising from 0.01 to 15% by weight, based on the total weight of the composition, of the compound of formula (1c) defined according to claim 2, and orally tolerable adjuvants.